FDA lifted the clinical hold on Salarius Pharmaceuticals Phase 1/2 trial in Ewing sarcoma

Radiopharm Theranostics received FDA Orphan Drug Designation for Trivehexin in Pancreatic Cancer

China NMPA Approved Innovent Bio’s Sintilimab + Bev + chemo for EGFR-mutated Non-sq NSCLC

Junshi Bio’s Tori plus Chemo combo showed encouraging data in ES-SCLC patients

BeiGene’s BRUKINSA is approved as a 1L treatment for CLL/SLL and WM in China